Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma

被引：5

作者：

Coiffier, B ^{[1
]}

Salles, G ^{[1
]}

机构：

[1] Ctr Hosp Lyon Sud, Dept Hematol, F-69495 Pierre Benite, France

来源：

BLOOD | 2004年 / 104卷 / 05期

关键词：

D O I：

10.1182/blood-2004-04-1266

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1584 / 1585

页数：2

共 10 条

[1] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[2]

COIFFIER B, 2004, PROGR ONCOLOGY, P220

[3]

COIFFIER B, 2003, P AN M AM SOC CLIN, V22, pA596

[4]

COIFFIER B, 2004, 8 WINT INT C HEM MAL

[5]

Habermann TM, 2003, BLOOD, V102, p6A

[6]

HOTTA T, 2003, P AN M AM SOC CLIN, V22, pA565

[7] Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas:: results of the NHL-B1 trial of the DSHNHL [J].

Pfreundschuh, M ;

Trümper, L ;

Kloess, M ;

Schmits, R ;

Feller, AC ;

Rudolph, C ;

Reiser, M ;

Hossfeld, DK ;

Metzner, B ;

Hasenclever, D ;

Schmitz, N ;

Glass, B ;

Rübe, C ;

Loeffler, M .

BLOOD, 2004, 104 (03) :626-633

[8] Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:: results of the NHL-B2 trial of the DSHNHL [J].

Pfreundschuh, M ;

Trümper, L ;

Kloess, M ;

Schmits, R ;

Feller, AC ;

Rübe, C ;

Rudolph, C ;

Reiser, M ;

Hossfeld, DK ;

Eimermacher, H ;

Hasenclever, D ;

Schmitz, N ;

Loeffler, M .

BLOOD, 2004, 104 (03) :634-641

[9]

PFREUNDSCHUH MG, 2003, P AN M AM SOC CLIN, V23, P556

[10]

Sehn LH, 2003, BLOOD, V102, p29A

← 1 →